Broken promises, lax scrutiny: Inside Massachusetts’s failure to regulate Steward Health
The phone call to Steward Health Care chief executive Ralph de la Torre from the state’s top health official came days after a veteran nurse
The phone call to Steward Health Care chief executive Ralph de la Torre from the state’s top health official came days after a veteran nurse
Novo Holdings, the parent company of Novo Nordisk, can proceed with its planned $16.5 billion acquisition of Catalent, a leading contract drug manufacturer, after U.S.
A U.S. government agency warned Sanofi that it faces sanctions over plans to change the way payments are made to most hospitals participating in a
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers,
The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients with circulating tumor DNA (ctDNA), failed to
Prostate cancer hijacks the normal prostate’s growth regulation program to release the brakes and grow freely, according to Weill Cornell Medicine researchers.
A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in predicting which patients
Researchers are shining a light on cancer cells’ energy centers – literally – to damage these power sources and trigger widespread cancer cell death.
Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk of recurrence based on the OncotypeDX genomic test had
More than six million Americans are affected by Alzheimer’s disease, a form of dementia marked by accumulation of amyloid-β within the brain. Amyloid-β is a